Global Continuous Glucose Monitoring (CGM) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 287859
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Continuous Glucose Monitoring (CGM) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Continuous Glucose Monitoring (CGM) market size is estimated to be worth US$ 12950 million in 2021 and is forecast to a readjusted size of USD 18810 million by 2028 with a CAGR of 5.5% during review period. Hospitals accounting for % of the Continuous Glucose Monitoring (CGM) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Transmitters segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Continuous Glucose Monitoring (CGM) include Pfizer, Baxter, Abbott Laboratories, Medtronic, and Animas, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Continuous Glucose Monitoring (CGM) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Transmitters

Sensors

Insulin Pumps

Market segment by Application can be divided into

Hospitals

Homecare Settings

Others

The key market players for global Continuous Glucose Monitoring (CGM) market are listed below:

Pfizer

Baxter

Abbott Laboratories

Medtronic

Animas

Novo Nordisk

Ypsomed

GlySens

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Continuous Glucose Monitoring (CGM) product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Continuous Glucose Monitoring (CGM), with price, sales, revenue and global market share of Continuous Glucose Monitoring (CGM) from 2019 to 2022.

Chapter 3, the Continuous Glucose Monitoring (CGM) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Continuous Glucose Monitoring (CGM) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Continuous Glucose Monitoring (CGM) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Continuous Glucose Monitoring (CGM).

Chapter 13, 14, and 15, to describe Continuous Glucose Monitoring (CGM) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Continuous Glucose Monitoring (CGM) Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Continuous Glucose Monitoring (CGM) Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Transmitters

1.2.3 Sensors

1.2.4 Insulin Pumps

1.3 Market Analysis by Application

1.3.1 Overview: Global Continuous Glucose Monitoring (CGM) Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Homecare Settings

1.3.4 Others

1.4 Global Continuous Glucose Monitoring (CGM) Market Size & Forecast

1.4.1 Global Continuous Glucose Monitoring (CGM) Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Continuous Glucose Monitoring (CGM) Sales in Volume (2017-2028)

1.4.3 Global Continuous Glucose Monitoring (CGM) Price (2017-2028)

1.5 Global Continuous Glucose Monitoring (CGM) Production Capacity Analysis

1.5.1 Global Continuous Glucose Monitoring (CGM) Total Production Capacity (2017-2028)

1.5.2 Global Continuous Glucose Monitoring (CGM) Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Continuous Glucose Monitoring (CGM) Market Drivers

1.6.2 Continuous Glucose Monitoring (CGM) Market Restraints

1.6.3 Continuous Glucose Monitoring (CGM) Trends Analysis

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Continuous Glucose Monitoring (CGM) Product and Services

2.1.4 Pfizer Continuous Glucose Monitoring (CGM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 Baxter

2.2.1 Baxter Details

2.2.2 Baxter Major Business

2.2.3 Baxter Continuous Glucose Monitoring (CGM) Product and Services

2.2.4 Baxter Continuous Glucose Monitoring (CGM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 Abbott Laboratories

2.3.1 Abbott Laboratories Details

2.3.2 Abbott Laboratories Major Business

2.3.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) Product and Services

2.3.4 Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Medtronic

2.4.1 Medtronic Details

2.4.2 Medtronic Major Business

2.4.3 Medtronic Continuous Glucose Monitoring (CGM) Product and Services

2.4.4 Medtronic Continuous Glucose Monitoring (CGM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Animas

2.5.1 Animas Details

2.5.2 Animas Major Business

2.5.3 Animas Continuous Glucose Monitoring (CGM) Product and Services

2.5.4 Animas Continuous Glucose Monitoring (CGM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 Novo Nordisk

2.6.1 Novo Nordisk Details

2.6.2 Novo Nordisk Major Business

2.6.3 Novo Nordisk Continuous Glucose Monitoring (CGM) Product and Services

2.6.4 Novo Nordisk Continuous Glucose Monitoring (CGM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 Ypsomed

2.7.1 Ypsomed Details

2.7.2 Ypsomed Major Business

2.7.3 Ypsomed Continuous Glucose Monitoring (CGM) Product and Services

2.7.4 Ypsomed Continuous Glucose Monitoring (CGM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8 GlySens

2.8.1 GlySens Details

2.8.2 GlySens Major Business

2.8.3 GlySens Continuous Glucose Monitoring (CGM) Product and Services

2.8.4 GlySens Continuous Glucose Monitoring (CGM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Continuous Glucose Monitoring (CGM) Breakdown Data by Manufacturer

3.1 Global Continuous Glucose Monitoring (CGM) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Continuous Glucose Monitoring (CGM) Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Continuous Glucose Monitoring (CGM)

3.4 Market Concentration Rate

3.4.1 Top 3 Continuous Glucose Monitoring (CGM) Manufacturer Market Share in 2021

3.4.2 Top 6 Continuous Glucose Monitoring (CGM) Manufacturer Market Share in 2021

3.5 Global Continuous Glucose Monitoring (CGM) Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Continuous Glucose Monitoring (CGM) Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Continuous Glucose Monitoring (CGM) Market Size by Region

4.1.1 Global Continuous Glucose Monitoring (CGM) Sales in Volume by Region (2017-2028)

4.1.2 Global Continuous Glucose Monitoring (CGM) Revenue by Region (2017-2028)

4.2 North America Continuous Glucose Monitoring (CGM) Revenue (2017-2028)

4.3 Europe Continuous Glucose Monitoring (CGM) Revenue (2017-2028)

4.4 Asia-Pacific Continuous Glucose Monitoring (CGM) Revenue (2017-2028)

4.5 South America Continuous Glucose Monitoring (CGM) Revenue (2017-2028)

4.6 Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Continuous Glucose Monitoring (CGM) Sales in Volume by Type (2017-2028)

5.2 Global Continuous Glucose Monitoring (CGM) Revenue by Type (2017-2028)

5.3 Global Continuous Glucose Monitoring (CGM) Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Continuous Glucose Monitoring (CGM) Sales in Volume by Application (2017-2028)

6.2 Global Continuous Glucose Monitoring (CGM) Revenue by Application (2017-2028)

6.3 Global Continuous Glucose Monitoring (CGM) Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Continuous Glucose Monitoring (CGM) Sales by Type (2017-2028)

7.2 North America Continuous Glucose Monitoring (CGM) Sales by Application (2017-2028)

7.3 North America Continuous Glucose Monitoring (CGM) Market Size by Country

7.3.1 North America Continuous Glucose Monitoring (CGM) Sales in Volume by Country (2017-2028)

7.3.2 North America Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Continuous Glucose Monitoring (CGM) Sales by Type (2017-2028)

8.2 Europe Continuous Glucose Monitoring (CGM) Sales by Application (2017-2028)

8.3 Europe Continuous Glucose Monitoring (CGM) Market Size by Country

8.3.1 Europe Continuous Glucose Monitoring (CGM) Sales in Volume by Country (2017-2028)

8.3.2 Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales by Type (2017-2028)

9.2 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales by Application (2017-2028)

9.3 Asia-Pacific Continuous Glucose Monitoring (CGM) Market Size by Region

9.3.1 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Continuous Glucose Monitoring (CGM) Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Continuous Glucose Monitoring (CGM) Sales by Type (2017-2028)

10.2 South America Continuous Glucose Monitoring (CGM) Sales by Application (2017-2028)

10.3 South America Continuous Glucose Monitoring (CGM) Market Size by Country

10.3.1 South America Continuous Glucose Monitoring (CGM) Sales in Volume by Country (2017-2028)

10.3.2 South America Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Type (2017-2028)

11.2 Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Application (2017-2028)

11.3 Middle East & Africa Continuous Glucose Monitoring (CGM) Market Size by Country

11.3.1 Middle East & Africa Continuous Glucose Monitoring (CGM) Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Continuous Glucose Monitoring (CGM) and Key Manufacturers

12.2 Manufacturing Costs Percentage of Continuous Glucose Monitoring (CGM)

12.3 Continuous Glucose Monitoring (CGM) Production Process

12.4 Continuous Glucose Monitoring (CGM) Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Continuous Glucose Monitoring (CGM) Typical Distributors

13.3 Continuous Glucose Monitoring (CGM) Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Continuous Glucose Monitoring (CGM) Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Continuous Glucose Monitoring (CGM) Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Pfizer Basic Information, Manufacturing Base and Competitors

Table 4. Pfizer Major Business

Table 5. Pfizer Continuous Glucose Monitoring (CGM) Product and Services

Table 6. Pfizer Continuous Glucose Monitoring (CGM) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Baxter Basic Information, Manufacturing Base and Competitors

Table 8. Baxter Major Business

Table 9. Baxter Continuous Glucose Monitoring (CGM) Product and Services

Table 10. Baxter Continuous Glucose Monitoring (CGM) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table 12. Abbott Laboratories Major Business

Table 13. Abbott Laboratories Continuous Glucose Monitoring (CGM) Product and Services

Table 14. Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Medtronic Basic Information, Manufacturing Base and Competitors

Table 16. Medtronic Major Business

Table 17. Medtronic Continuous Glucose Monitoring (CGM) Product and Services

Table 18. Medtronic Continuous Glucose Monitoring (CGM) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Animas Basic Information, Manufacturing Base and Competitors

Table 20. Animas Major Business

Table 21. Animas Continuous Glucose Monitoring (CGM) Product and Services

Table 22. Animas Continuous Glucose Monitoring (CGM) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. Novo Nordisk Basic Information, Manufacturing Base and Competitors

Table 24. Novo Nordisk Major Business

Table 25. Novo Nordisk Continuous Glucose Monitoring (CGM) Product and Services

Table 26. Novo Nordisk Continuous Glucose Monitoring (CGM) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. Ypsomed Basic Information, Manufacturing Base and Competitors

Table 28. Ypsomed Major Business

Table 29. Ypsomed Continuous Glucose Monitoring (CGM) Product and Services

Table 30. Ypsomed Continuous Glucose Monitoring (CGM) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. GlySens Basic Information, Manufacturing Base and Competitors

Table 32. GlySens Major Business

Table 33. GlySens Continuous Glucose Monitoring (CGM) Product and Services

Table 34. GlySens Continuous Glucose Monitoring (CGM) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 35. Global Continuous Glucose Monitoring (CGM) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)

Table 36. Global Continuous Glucose Monitoring (CGM) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 37. Market Position of Manufacturers in Continuous Glucose Monitoring (CGM), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 38. Global Continuous Glucose Monitoring (CGM) Production Capacity by Company, (K Units): 2020 VS 2021

Table 39. Head Office and Continuous Glucose Monitoring (CGM) Production Site of Key Manufacturer

Table 40. Continuous Glucose Monitoring (CGM) New Entrant and Capacity Expansion Plans

Table 41. Continuous Glucose Monitoring (CGM) Mergers & Acquisitions in the Past Five Years

Table 42. Global Continuous Glucose Monitoring (CGM) Sales by Region (2017-2022) & (K Units)

Table 43. Global Continuous Glucose Monitoring (CGM) Sales by Region (2023-2028) & (K Units)

Table 44. Global Continuous Glucose Monitoring (CGM) Revenue by Region (2017-2022) & (USD Million)

Table 45. Global Continuous Glucose Monitoring (CGM) Revenue by Region (2023-2028) & (USD Million)

Table 46. Global Continuous Glucose Monitoring (CGM) Sales by Type (2017-2022) & (K Units)

Table 47. Global Continuous Glucose Monitoring (CGM) Sales by Type (2023-2028) & (K Units)

Table 48. Global Continuous Glucose Monitoring (CGM) Revenue by Type (2017-2022) & (USD Million)

Table 49. Global Continuous Glucose Monitoring (CGM) Revenue by Type (2023-2028) & (USD Million)

Table 50. Global Continuous Glucose Monitoring (CGM) Price by Type (2017-2022) & (USD/Unit)

Table 51. Global Continuous Glucose Monitoring (CGM) Price by Type (2023-2028) & (USD/Unit)

Table 52. Global Continuous Glucose Monitoring (CGM) Sales by Application (2017-2022) & (K Units)

Table 53. Global Continuous Glucose Monitoring (CGM) Sales by Application (2023-2028) & (K Units)

Table 54. Global Continuous Glucose Monitoring (CGM) Revenue by Application (2017-2022) & (USD Million)

Table 55. Global Continuous Glucose Monitoring (CGM) Revenue by Application (2023-2028) & (USD Million)

Table 56. Global Continuous Glucose Monitoring (CGM) Price by Application (2017-2022) & (USD/Unit)

Table 57. Global Continuous Glucose Monitoring (CGM) Price by Application (2023-2028) & (USD/Unit)

Table 58. North America Continuous Glucose Monitoring (CGM) Sales by Country (2017-2022) & (K Units)

Table 59. North America Continuous Glucose Monitoring (CGM) Sales by Country (2023-2028) & (K Units)

Table 60. North America Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2022) & (USD Million)

Table 61. North America Continuous Glucose Monitoring (CGM) Revenue by Country (2023-2028) & (USD Million)

Table 62. North America Continuous Glucose Monitoring (CGM) Sales by Type (2017-2022) & (K Units)

Table 63. North America Continuous Glucose Monitoring (CGM) Sales by Type (2023-2028) & (K Units)

Table 64. North America Continuous Glucose Monitoring (CGM) Sales by Application (2017-2022) & (K Units)

Table 65. North America Continuous Glucose Monitoring (CGM) Sales by Application (2023-2028) & (K Units)

Table 66. Europe Continuous Glucose Monitoring (CGM) Sales by Country (2017-2022) & (K Units)

Table 67. Europe Continuous Glucose Monitoring (CGM) Sales by Country (2023-2028) & (K Units)

Table 68. Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2022) & (USD Million)

Table 69. Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2023-2028) & (USD Million)

Table 70. Europe Continuous Glucose Monitoring (CGM) Sales by Type (2017-2022) & (K Units)

Table 71. Europe Continuous Glucose Monitoring (CGM) Sales by Type (2023-2028) & (K Units)

Table 72. Europe Continuous Glucose Monitoring (CGM) Sales by Application (2017-2022) & (K Units)

Table 73. Europe Continuous Glucose Monitoring (CGM) Sales by Application (2023-2028) & (K Units)

Table 74. Asia-Pacific Continuous Glucose Monitoring (CGM) Sales by Region (2017-2022) & (K Units)

Table 75. Asia-Pacific Continuous Glucose Monitoring (CGM) Sales by Region (2023-2028) & (K Units)

Table 76. Asia-Pacific Continuous Glucose Monitoring (CGM) Revenue by Region (2017-2022) & (USD Million)

Table 77. Asia-Pacific Continuous Glucose Monitoring (CGM) Revenue by Region (2023-2028) & (USD Million)

Table 78. Asia-Pacific Continuous Glucose Monitoring (CGM) Sales by Type (2017-2022) & (K Units)

Table 79. Asia-Pacific Continuous Glucose Monitoring (CGM) Sales by Type (2023-2028) & (K Units)

Table 80. Asia-Pacific Continuous Glucose Monitoring (CGM) Sales by Application (2017-2022) & (K Units)

Table 81. Asia-Pacific Continuous Glucose Monitoring (CGM) Sales by Application (2023-2028) & (K Units)

Table 82. South America Continuous Glucose Monitoring (CGM) Sales by Country (2017-2022) & (K Units)

Table 83. South America Continuous Glucose Monitoring (CGM) Sales by Country (2023-2028) & (K Units)

Table 84. South America Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2022) & (USD Million)

Table 85. South America Continuous Glucose Monitoring (CGM) Revenue by Country (2023-2028) & (USD Million)

Table 86. South America Continuous Glucose Monitoring (CGM) Sales by Type (2017-2022) & (K Units)

Table 87. South America Continuous Glucose Monitoring (CGM) Sales by Type (2023-2028) & (K Units)

Table 88. South America Continuous Glucose Monitoring (CGM) Sales by Application (2017-2022) & (K Units)

Table 89. South America Continuous Glucose Monitoring (CGM) Sales by Application (2023-2028) & (K Units)

Table 90. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Region (2017-2022) & (K Units)

Table 91. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Region (2023-2028) & (K Units)

Table 92. Middle East & Africa Continuous Glucose Monitoring (CGM) Revenue by Region (2017-2022) & (USD Million)

Table 93. Middle East & Africa Continuous Glucose Monitoring (CGM) Revenue by Region (2023-2028) & (USD Million)

Table 94. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Type (2017-2022) & (K Units)

Table 95. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Type (2023-2028) & (K Units)

Table 96. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Application (2017-2022) & (K Units)

Table 97. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Application (2023-2028) & (K Units)

Table 98. Continuous Glucose Monitoring (CGM) Raw Material

Table 99. Key Manufacturers of Continuous Glucose Monitoring (CGM) Raw Materials

Table 100. Direct Channel Pros & Cons

Table 101. Indirect Channel Pros & Cons

Table 102. Continuous Glucose Monitoring (CGM) Typical Distributors

Table 103. Continuous Glucose Monitoring (CGM) Typical Customers

List of Figures

Figure 1. Continuous Glucose Monitoring (CGM) Picture

Figure 2. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Type in 2021

Figure 3. Transmitters

Figure 4. Sensors

Figure 5. Insulin Pumps

Figure 6. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Application in 2021

Figure 7. Hospitals

Figure 8. Homecare Settings

Figure 9. Others

Figure 10. Global Continuous Glucose Monitoring (CGM) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028

Figure 11. Global Continuous Glucose Monitoring (CGM) Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Continuous Glucose Monitoring (CGM) Sales (2017-2028) & (K Units)

Figure 13. Global Continuous Glucose Monitoring (CGM) Price (2017-2028) & (USD/Unit)

Figure 14. Global Continuous Glucose Monitoring (CGM) Production Capacity (2017-2028) & (K Units)

Figure 15. Global Continuous Glucose Monitoring (CGM) Production Capacity by Geographic Region: 2022 VS 2028

Figure 16. Continuous Glucose Monitoring (CGM) Market Drivers

Figure 17. Continuous Glucose Monitoring (CGM) Market Restraints

Figure 18. Continuous Glucose Monitoring (CGM) Market Trends

Figure 19. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Manufacturer in 2021

Figure 20. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Manufacturer in 2021

Figure 21. Continuous Glucose Monitoring (CGM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 22. Top 3 Continuous Glucose Monitoring (CGM) Manufacturer (Revenue) Market Share in 2021

Figure 23. Top 6 Continuous Glucose Monitoring (CGM) Manufacturer (Revenue) Market Share in 2021

Figure 24. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2017-2028)

Figure 25. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Region (2017-2028)

Figure 26. North America Continuous Glucose Monitoring (CGM) Revenue (2017-2028) & (USD Million)

Figure 27. Europe Continuous Glucose Monitoring (CGM) Revenue (2017-2028) & (USD Million)

Figure 28. Asia-Pacific Continuous Glucose Monitoring (CGM) Revenue (2017-2028) & (USD Million)

Figure 29. South America Continuous Glucose Monitoring (CGM) Revenue (2017-2028) & (USD Million)

Figure 30. Middle East & Africa Continuous Glucose Monitoring (CGM) Revenue (2017-2028) & (USD Million)

Figure 31. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2017-2028)

Figure 32. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Type (2017-2028)

Figure 33. Global Continuous Glucose Monitoring (CGM) Price by Type (2017-2028) & (USD/Unit)

Figure 34. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2017-2028)

Figure 35. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Application (2017-2028)

Figure 36. Global Continuous Glucose Monitoring (CGM) Price by Application (2017-2028) & (USD/Unit)

Figure 37. North America Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2017-2028)

Figure 38. North America Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2017-2028)

Figure 39. North America Continuous Glucose Monitoring (CGM) Sales Market Share by Country (2017-2028)

Figure 40. North America Continuous Glucose Monitoring (CGM) Revenue Market Share by Country (2017-2028)

Figure 41. United States Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Canada Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Mexico Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Europe Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2017-2028)

Figure 45. Europe Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2017-2028)

Figure 46. Europe Continuous Glucose Monitoring (CGM) Sales Market Share by Country (2017-2028)

Figure 47. Europe Continuous Glucose Monitoring (CGM) Revenue Market Share by Country (2017-2028)

Figure 48. Germany Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. France Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. United Kingdom Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Russia Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Italy Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Asia-Pacific Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2017-2028)

Figure 54. Asia-Pacific Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2017-2028)

Figure 55. Asia-Pacific Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2017-2028)

Figure 56. Asia-Pacific Continuous Glucose Monitoring (CGM) Revenue Market Share by Region (2017-2028)

Figure 57. China Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Japan Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Korea Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. India Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Southeast Asia Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Australia Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South America Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2017-2028)

Figure 64. South America Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2017-2028)

Figure 65. South America Continuous Glucose Monitoring (CGM) Sales Market Share by Country (2017-2028)

Figure 66. South America Continuous Glucose Monitoring (CGM) Revenue Market Share by Country (2017-2028)

Figure 67. Brazil Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Argentina Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2017-2028)

Figure 70. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2017-2028)

Figure 71. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2017-2028)

Figure 72. Middle East & Africa Continuous Glucose Monitoring (CGM) Revenue Market Share by Region (2017-2028)

Figure 73. Turkey Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Egypt Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. South Africa Continuous Glucose Monitoring (CGM) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Manufacturing Cost Structure Analysis of Continuous Glucose Monitoring (CGM) in 2021

Figure 78. Manufacturing Process Analysis of Continuous Glucose Monitoring (CGM)

Figure 79. Continuous Glucose Monitoring (CGM) Industrial Chain

Figure 80. Sales Channel: Direct Channel vs Indirect Channel

Figure 81. Methodology

Figure 82. Research Process and Data Source